Establishes cap on amount that hospital can charge patients for laboratory services to 150% of Medicare.
Impact
If enacted, A2471 will significantly influence hospital billing practices, particularly for patients who may not be insured or do not meet specific income thresholds established under previous laws. The existing law, P.L.2008, c.60, provides that uninsured patients with a family gross income below 500% of the federal poverty level can only be charged 115% of the Medicare rate. The new bill extends similar protective measures to a broader range of patients, ensuring a uniform pricing structure for lab services.
Summary
Assembly Bill A2471 seeks to regulate the amounts that hospitals can charge patients for laboratory services in New Jersey. It establishes a cap limiting these charges to 150% of the applicable payment rate determined by Medicare. The purpose of the bill is to ensure that patients are not overcharged for essential laboratory services, reflecting a growing concern over healthcare costs and patient financial burdens.
Contention
The bill's introduction has sparked discussions regarding the implications for hospital revenue and patient access to necessary services. Opponents may argue that imposing a cap could limit hospitals' ability to recover costs and impact operational sustainability. However, supporters posit that the legislative measure is a crucial step in making healthcare more affordable and tackling the financial disparities faced by patients in paying for medical services.
Requires hospital laboratories and bio-analytical or clinical laboratories to offer test for hepatitis C to certain individuals; authorizes certain laboratories to perform rapid tests for hepatitis C.
Requires hospital laboratories and bio-analytical or clinical laboratories to offer test for hepatitis C to certain individuals; authorizes certain laboratories to perform rapid tests for hepatitis C.
Requires hospital, bio-analytical, and clinical laboratories to provide information and offer of HIV screening to patients living in areas with high prevalence of HIV.
Requires hospital, bio-analytical, and clinical laboratories to provide information and offer of HIV screening to patients living in areas with high prevalence of HIV.